Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8598 |
High Similarity |
NPD5844 |
Phase 1 |
0.8378 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8378 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8344 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8323 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8299 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8293 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.825 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8221 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8199 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8144 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8137 |
Intermediate Similarity |
NPD37 |
Approved |
0.8121 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8108 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8098 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8098 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8086 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.807 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8041 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7988 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7988 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7941 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7917 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7867 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7866 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7849 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7812 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7763 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7746 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7657 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7657 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7654 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7654 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7625 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7619 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7576 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7566 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7548 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7545 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7545 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7517 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7240 |
Approved |
0.75 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5403 |
Approved |
0.75 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7457 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD4749 |
Approved |
0.74 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7389 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7375 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7346 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7346 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7341 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7338 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7318 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6099 |
Approved |
0.731 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7308 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7303 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7278 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7273 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7267 |
Intermediate Similarity |
NPD919 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7222 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7215 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7208 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7207 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7207 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2796 |
Approved |
0.72 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7182 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7099 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7089 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7086 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7075 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7066 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7051 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7029 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7027 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7026 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7017 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7013 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD228 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD5709 |
Phase 3 |
0.6964 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6962 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD1933 |
Approved |
0.6951 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD6800 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6951 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6948 |
Remote Similarity |
NPD1535 |
Discovery |
0.6946 |
Remote Similarity |
NPD6667 |
Approved |
0.6946 |
Remote Similarity |
NPD6666 |
Approved |
0.6943 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6937 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD7157 |
Approved |
0.6933 |
Remote Similarity |
NPD6671 |
Approved |
0.6928 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD4626 |
Approved |
0.6928 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6923
|
Remote Similarity |
NPD6273 |
Approved |